We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy

    Studies from high endemic areas, mostly China, indicate that surface antigen positive (HBsAg pos ) chronic hepatitis B virus (HBV) infection is...

    Marcella Visentini, Andrea Pica, ... Alessandro Pulsoni in Annals of Hematology
    Article Open access 31 August 2023
  2. Bulevirtid bei Hepatitis B mit Hepatitis-D-Virus-Koinfektion

    Elena Durmashkina, Christoph Sarrazin, S. Nitschmann in Die Innere Medizin
    Article 15 May 2024
  3. Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014–2019

    Background

    Hepatitis B and C viruses are the major public health concerns of the globe. The two hepatotropic viruses share common modes of...

    Haftom Legese, Brhane Berhe, ... Hadush Negash in BMC Gastroenterology
    Article Open access 19 May 2023
  4. Identification of associated risk factors for serological distribution of hepatitis B virus via machine learning models

    Background

    The provincial-level sero-survey was launched to learn the updated seroprevalence of hepatitis B virus (HBV) infection in the general...

    Ning Yao, Yang Liu, ... Yazhou Wu in BMC Infectious Diseases
    Article Open access 09 January 2024
  5. Management of Hepatitis B in Pregnancy

    Purpose of Review

    In 2016, WHO sets a target to eliminate viral hepatitis as a public health threat by 2030, with significant emphasis placed on...

    Jeanette Rios, Lital Aliasi-Sinai, ... Tatyana Kushner in Current Hepatology Reports
    Article 26 February 2024
  6. Evaluating the impact of COVID-19 outbreak on hepatitis B and forecasting the epidemiological trend in mainland China: a causal analysis

    Background

    It is uncertain how COVID-19 outbreak influences the hepatitis B epidemics. This study aims to evaluate the effects on hepatitis B owing to...

    Chao-Qun He, Bai-Hong Sun, ... Wei Wu in BMC Public Health
    Article Open access 02 January 2024
  7. Effect of interferon therapy on quality of life in patients with chronic hepatitis B

    Interferon therapy is the most effective treatment for achieving clinical cure in chronic hepatitis B (CHB) patients. However, the treatment outcomes...

    Mengdi Zhang, Meijuan Wan, ... ** Zhang in Scientific Reports
    Article Open access 30 January 2024
  8. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection

    Hepatitis B virus (HBV) vaccine is composed of the purified hepatitis B surface antigen (HBsAg) that is produced by recombinant DNA technology. The...

    Mohammed El-Mowafy, Mohamed Elegezy, ... Abdelaziz Elgaml in Virus Genes
    Article 13 February 2024
  9. Hepatitis Viruses

    Illness with episodes of jaundice described by Hippocrates 400 years ago probably corresponded to viral hepatitis. Two separate disease...
    Krishna Gopal Narayan, Dharmendra Kumar Sinha, Dhirendra Kumar Singh in Veterinary Public Health & Epidemiology
    Chapter 2023
  10. Evidence-Based Strategies for Micro-elimination of Chronic Hepatitis B Virus Infection

    Purpose of Review

    Hepatitis B (HBV) remains a health threat around the world. Hepatitis C is closer to meeting the World Health Organization’s 2030...

    Katerina Roma, Mark Hsu, ... Robert Gish in Current Hepatology Reports
    Article Open access 29 July 2023
  11. The Influence of ESR2 Gene Polymorphisms on Susceptibility to Hepatitis B Virus-Related Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma

    Hepatocellular carcinoma (HCC) represents an estrogen-dependent tumor. The action of estrogen is regulated via estrogen receptor (ER). Polymorphisms...

    Zeng Jie, Jiang Hongkun, ... Lu Yu in Biochemical Genetics
    Article 21 January 2024
  12. Assessing Physicians’ Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City

    Deaths from liver cancer are on the rise and disproportionately affect minority racial/ethnic groups. In this study, we examined associations between...

    Thoin F. Begum, Vidya S Patil, ... Yin Tan in Journal of Community Health
    Article 29 January 2024
  13. The scientific basis of combination therapy for chronic hepatitis B functional cure

    Functional cure of chronic hepatitis B (CHB) — or hepatitis B surface antigen (HBsAg) loss after 24 weeks off therapy — is now the goal of treatment,...

    Seng Gee Lim, Thomas F. Baumert, ... Fabien Zoulim in Nature Reviews Gastroenterology & Hepatology
    Article 11 January 2023
  14. Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques

    An effective HIV-1 vaccine remains a critical unmet need for ending the AIDS epidemic. Vaccine trials conducted to date have suggested the need to...

    Danielle Nettere, Shakthi Unnithan, ... Justin Pollara in npj Vaccines
    Article Open access 24 November 2023
  15. Facilitators and barriers to accessing hepatitis B care in the postpartum period among foreign-born New Yorkers: a qualitative analysis of case notes

    Background

    Approximately 241,000 people are living with hepatitis B in New York City. Among those living with hepatitis B, pregnant people are...

    Liz Y. Tang, Farma Pene, ... María C. Baquero in BMC Public Health
    Article Open access 08 January 2024
  16. Preventing early childhood transmission of hepatitis B in remote Aboriginal communities in northern Australia

    Background

    Chronic hepatitis B is a public health concern in Aboriginal communities in the Northern Territory of Australia with prevalence almost four...

    Richard P. Sullivan, Jane Davies, ... Joshua S. Davis in International Journal for Equity in Health
    Article Open access 28 December 2022
  17. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B

    Background and Aims

    Functional cure is difficult to achieve using current antiviral therapies; moreover, limited data are available regarding...

    Min Zhang, **g Li, ... Fu-Sheng Wang in Hepatology International
    Article Open access 20 February 2024
  18. Origin and dispersal history of Hepatitis B virus in Eastern Eurasia

    Hepatitis B virus is a globally distributed pathogen and the history of HBV infection in humans predates 10000 years. However, long-term evolutionary...

    Bing Sun, Aida Andrades Valtueña, ... Yinqiu Cui in Nature Communications
    Article Open access 05 April 2024
  19. Modelling of Hepatitis B Virus vertical transmission dynamics in Ethiopia: a compartmental modelling approach

    Background

    Hepatitis B (HB) is a virus which causes a potentially fatal liver infection. It is a DNA virus belonging to the Hepadnaviridae virus...

    Denekew Tenaw Anley, Mequanente Dagnaw, ... Yayehirad Alemu Melsew in BMC Infectious Diseases
    Article Open access 31 May 2023
  20. Modeling hepatitis B infection dynamics with a novel mathematical model incorporating convex incidence rate and real data

    In this study, we present a novel mathematical model that comprehensively addresses the mechanics of hepatitis B infection propagation, caused by the...

    Rahat Zarin, Abdur Raouf, ... Usa Wannasingha Humphries in The European Physical Journal Plus
    Article 29 November 2023
Did you find what you were looking for? Share feedback.